Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -187,571 | -79,074 | -303,659 | -196,711 | -136,542 |
| Depreciation Amortization | 2,713 | 1,502 | 6,364 | 4,503 | 2,196 |
| Accounts receivable | -3,340 | 541 | 11,032 | 11,939 | 5,213 |
| Other Working Capital | 43,549 | 344 | 50,352 | -8,730 | -14,026 |
| Other Operating Activity | 32,238 | 14,805 | 20,203 | 11,182 | 11,833 |
| Operating Cash Flow | $-112,410 | $-61,882 | $-215,709 | $-177,817 | $-131,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,746 | 23,332 | -348,953 | -168,263 | -224,390 |
| PPE Investments | -717 | N/A | -1,231 | -587 | -419 |
| Purchase Of Investment | -2,000 | -2,000 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | 174,840 | N/A | N/A |
| Investing Cash Flow | $11,028 | $21,332 | $-175,345 | $-168,851 | $-224,809 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 72,711 | 29,448 | 216,110 | 168,515 | 168,260 |
| Other Financing Activity | -1,350 | -1,026 | -4,611 | -4,611 | -3,915 |
| Financing Cash Flow | $71,361 | $28,422 | $211,499 | $163,904 | $164,345 |
| Exchange Rate Effect | -21 | -7 | -30 | -23 | -12 |
| Beginning Cash Position | 71,144 | 71,144 | 250,728 | 250,728 | 250,728 |
| End Cash Position | 41,102 | 59,010 | 71,144 | 67,941 | 58,925 |
| Net Cash Flow | $-30,042 | $-12,134 | $-179,584 | $-182,787 | $-191,803 |
| Free Cash Flow | |||||
| Operating Cash Flow | -112,410 | -61,882 | -215,709 | -177,817 | -131,327 |
| Capital Expenditure | -717 | N/A | -1,231 | -587 | -419 |
| Free Cash Flow | -113,127 | -61,882 | -216,940 | -178,405 | -131,745 |